118 related articles for article (PubMed ID: 15544130)
1. [The lower LDL cholesterol the better!].
Stenestrand U; Olsson AG
Lakartidningen; 2004 Oct; 101(42):3246-7. PubMed ID: 15544130
[No Abstract] [Full Text] [Related]
2. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
Olsson AG
Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
[No Abstract] [Full Text] [Related]
3. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
[No Abstract] [Full Text] [Related]
4. [Should cholesterol levels be reduced more aggressively?].
Ravnskov U
Lakartidningen; 2005 Sep 12-18; 102(37):2583-4; discussion 2584. PubMed ID: 16200908
[No Abstract] [Full Text] [Related]
5. [Misleading advice on cholesterol reduction].
Ravnskov U
Lakartidningen; 2006 Feb 22-28; 103(8):568; discussion 569. PubMed ID: 16570784
[No Abstract] [Full Text] [Related]
6. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
7. [MMW- Drug Prize 2005 for simvastatin/ezetimib (Inegy). LDL goal values are easier to reach now].
Füessl HS
MMW Fortschr Med; 2005 Oct; 147(43):13. PubMed ID: 16302413
[No Abstract] [Full Text] [Related]
8. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
Carlson LA
Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
[No Abstract] [Full Text] [Related]
9. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
Olsson AG
Lakartidningen; 2006 Jan 11-17; 103(1-2):22-3. PubMed ID: 16465841
[No Abstract] [Full Text] [Related]
10. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
Zhao SP
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
[No Abstract] [Full Text] [Related]
11. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
MMW Fortschr Med; 2006 Nov; 148(48):54-5. PubMed ID: 17615773
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
13. [LDL lowering--level and time. Maybe two equally important parameters for protection against arteriosclerosis].
Herlitz J
Lakartidningen; 2006 Oct 25-31; 103(43):3272-3. PubMed ID: 17117658
[No Abstract] [Full Text] [Related]
14. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
[No Abstract] [Full Text] [Related]
15. [Lowering cholesterol: how low is low enough?].
Czuriga I; Edes I
Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
[TBL] [Abstract][Full Text] [Related]
16. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
17. [Lower and lower cholesterol targets increase adverse effects].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B; ;
Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2550-1. PubMed ID: 19908628
[No Abstract] [Full Text] [Related]
18. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
19. Enhanced LDL-C reduction: lower is better. Does it matter how?
Viljoen A; Wierzbicki AS
Int J Clin Pract; 2008 Apr; 62(4):518-20. PubMed ID: 18324945
[No Abstract] [Full Text] [Related]
20. [Few patients with coronary diseases are receiving lipid-lowering therapy].
Stagmo M; Hofman-Bang C; Erhardt L; Rydén L
Lakartidningen; 2002 Apr; 99(16):1798-9, 1802-3. PubMed ID: 12043479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
